JP Morgan Chase
CLOV icon

JP Morgan Chase’s Clover Health Investments CLOV Stock Holding History

JP Morgan Chase’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Sell
296,369
-40,726
-12% -$138K ﹤0.01% 4320
2026
Q1 		$580K Buy
337,095
+25,603
+8% +$55.5K ﹤0.01% 4910
2025
Q4 		$732K Sell
311,492
-3,753
-1% -$10.3K ﹤0.01% 4796
2025
Q3 		$965K Sell
315,245
-318,455
-50% -$910K ﹤0.01% 4626
2025
Q2 		$1.77M Buy
633,700
+186,047
+42% +$612K ﹤0.01% 4004
2025
Q1 		$1.61M Buy
447,653
+15,385
+4% +$61.8K ﹤0.01% 4024
2024
Q4 		$1.36M Buy
432,268
+273,348
+172% +$977K ﹤0.01% 4407
2024
Q3 		$448K Buy
+158,920
New +$364K ﹤0.01% 4965
2024
Q2 		– Sell
-868,542
Closed -$690K – 7395
2024
Q1 		$690K Buy
868,542
+741,421
+583% +$675K ﹤0.01% 4596
2023
Q4 		$121K Buy
127,121
+125,400
+7,286% +$123K ﹤0.01% 5647
2023
Q3 		$1.86K Hold
1,721
– – ﹤0.01% 6560
2023
Q2 		$1.54K Sell
1,721
-460,156
-100% -$408K ﹤0.01% 6385
2023
Q1 		$390K Buy
461,877
+92,006
+25% +$101K ﹤0.01% 4647
2022
Q4 		$344K Buy
369,871
+35,233
+11% +$47K ﹤0.01% 4745
2022
Q3 		$569K Buy
334,638
+11,882
+4% +$31.1K ﹤0.01% 4368
2022
Q2 		$691K Buy
322,756
+245,037
+315% +$651K ﹤0.01% 4356
2022
Q1 		$276K Buy
77,719
+7,199
+10% +$20.9K ﹤0.01% 5011
2021
Q4 		$262K Sell
70,520
-65,535
-48% -$402K ﹤0.01% 5198
2021
Q3 		$1M Buy
136,055
+110,072
+424% +$942K ﹤0.01% 4306
2021
Q2 		$346K Buy
+25,983
New +$255K ﹤0.01% 4928
2021
Q1 		– Sell
-2,522
Closed -$42K – 6091
2020
Q4 		$42K Buy
+2,522
New +$28.1K ﹤0.01% 5192

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase's CLOV Position: Q2 2026 in Review

JP Morgan Chase reduced its Clover Health Investments (CLOV) stake by 12% in Q2 2026, selling an estimated $138K and leaving 296,369 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #4320.

JP Morgan Chase first reported a position in CLOV in Q4 2020 and has held it in 21 quarters since. The position peaked at $1.77M in Q2 2025. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • JP Morgan Chase held 296,369 shares of Clover Health Investments worth $1.67M as of Q2 2026.
  • JP Morgan Chase sold 40,726 Clover Health Investments shares in Q2 2026, an estimated $138K.
  • Clover Health Investments made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4320 holding.
  • JP Morgan Chase first reported a position in Clover Health Investments in Q4 2020 and has held it in 21 quarters since.
  • JP Morgan Chase's Clover Health Investments position peaked at $1.77M in Q2 2025.
  • 226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.